
An investor, who purchased shares of Invivyd, Inc. (NASDAQ:IVVD), filed a lawsuit over alleged violations of Federal Securities Laws by Invivyd, Inc. f.k.a. Adagio Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between November 29, 2021 and December 14, 2021.